cannabichromene

chemical compound

Uses your system voice; voice and rate in settings.

Q410949Snapshot

≈ 1 min read

Names in other languages

  • Englishcannabichromene
  • DeutschCannabichromen
  • Polskikannabichromen
  • ČeštinaKanabichromen
  • Portuguêscanabicromeno
  • shKanabihromen
  • СрпскиKanabihromen
  • فارسیکانابیچرومن

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cannabichromene (CBC), also called cannabichrome, cannanbichromene, pentylcannabichromene or cannabinochromene, is a phytocannabinoid, one of the hundreds of cannabinoids found in the Cannabis plant. It bears structural similarity to the other natural cannabinoids, including tetrahydrocannabinol (THC), tetrahydrocannabivarin (THCV), cannabidiol (CBD), and cannabinol (CBN), among others. It is not scheduled by the Convention on Psychotropic Substances.

Pharmacology

Cannabichromene has been hypothesized to affect THC psychoactivity, though in vivo effects have not been demonstrated. CBC acts on the TRPV1 and TRPA1 receptors, interfering with their ability to break down endocannabinoids (chemicals such as anandamide and 2-AG that the body creates naturally). CBC has shown antitumor effects in breast cancer xenoplants in mice.

It also has anticonvulsant activity in a mouse model. In vitro, CBC binds weakly to CB1 and CB2 with binding affinities of 713 nM and 256 nM, respectively, which are significantly lower than that for THC with 35 nM at CB1. acting as an agonist for cAMP stimulation and an antagonist at beta-arrestin. Additionally, CBC is an agonist of TRPA1, and less potently TRPV3 and TRPV4.

CBC has two stereoisomers.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368874681 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.